Investment
Features
FeesSafety
Academy
More
Pluang+

Compare RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade
UBS Group AG Registered Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) vs UBS Group AG Registered Ordinary Shares — how do they compare? RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $36.73 (market cap $63.57B), while UBS Group AG Registered Ordinary Shares trades at $47.21 (market cap $147.14B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 2.3× RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)'s market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.49%). Which is the better fit depends on your goals.

RELXUBS
Market Cap
$63.57B$147.14B
Volume
1,602,0931,589,541
Sector
IndustrialsFinancials
52-Week High
$46.80$55.72
52-Week Low
$27.73$36.41
Enterprise Value
$75.05B$315.77B
Dividend Yield
2.49%2.3%
Typical Hold Time
—3 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

UBS Group AG Registered Ordinary Shares

UBS trades at $47.85, showing minimal daily movement with a 0.06% gain. The technical picture is bearish with mixed earnings performance - beating estimates in Q1 2026 but missing in Q4 2025 and Q2 2026. Analyst sentiment leans positive with 55% buy ratings, though the consensus price target of $23.57 sits well below current levels. Recent news highlights UBS's strategic focus on US expansion and ongoing integration challenges.

The outlook remains cautious given the bearish technical signals and valuation concerns. Investment opportunity exists in the company's improving profitability and revenue growth trajectory, but risks include integration challenges from recent acquisitions and exposure to European debt market volatility. The significant gap between current price and analyst targets warrants careful consideration.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RELX

No sentiment data available yet.

UBS
100% Buy0% Sell
Avg holding period · 3 Days

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →

About UBS Group AG Registered Ordinary Shares

UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.

Read more on UBS →